Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Oct 5, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 413
- Market value to sell
- $1.41B
- Sellers
- 117
- Companies
- 37
- Under 10b5-1 plans
- 220
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| ADPTAdaptive Biotechnologies Corp | Dec 1, 20256:03 PM ET | Chad RobinsOfficer | 125.0K | $2.35M | Dec 1, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Dec 1, 20254:07 PM ET | Howard WelgusDirector | 10.0K | $302.1K | Dec 1, 202510b5-1 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Dec 1, 20254:06 PM ET | Masaru MatsudaOfficer | 1.66K | $50.1K | Dec 1, 202510b5-1 | Merrill Lynch | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 28, 20251:18 PM ET | Kyle PiskelOfficer | 162.8K | $3.21M | Nov 28, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 26, 20255:30 PM ET | Chad RobinsOfficer | 35.7K | $704.7K | Nov 26, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| ASPIASP Isotopes Inc. | Nov 25, 20259:30 PM ET | Mann Paul ElliotDirector ยท Officer | 324.7K | $2.11M | Nov 15, 202510b5-1 | Independent Trading Group (ITG) Inc. | SEC |
| VIRVir Biotechnology, Inc. | Nov 25, 20259:00 PM ET | SVF Endurance (Cayman) Limited10% stockholder | 1.25M | $8.06M | Nov 25, 202510b5-1 | BTIG, LLC | SEC |
| MARMarriott International Inc | Nov 25, 20253:53 PM ET | Lee FelitiaOfficer | 373 | $113.3K | Nov 25, 2025 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Nov 25, 202510:55 AM ET | Lee FelitiaOfficer | 500 | $150.0K | Nov 25, 2025 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 24, 20254:58 PM ETAmended | Benzeno SharonOfficer | 308.5K | $5.03M | Nov 21, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 24, 20254:01 PM ET | Sue-Jean LinDirector | 25.3K | $778.0K | Nov 24, 2025 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 24, 20253:55 PM ET | Todd Franklin WatanabeOfficer | 48.9K | $1.49M | Nov 24, 202510b5-1 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 21, 20254:49 PM ET | Todd Franklin WatanabeOfficer | 1.05K | $31.6K | Nov 21, 202510b5-1 | Merrill Lynch | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 20, 20254:25 PM ET | Sharon BenzenoOfficer | 202.0K | $3.06M | Nov 20, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 20, 20254:24 PM ET | Halley GilbertDirector | 16.5K | $455.4K | Nov 20, 2025 | Merrill | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 19, 20254:22 PM ET | Sharon BenzenoOfficer | 95.9K | $1.32M | Nov 19, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 19, 20254:20 PM ET | Masaru MatsudaOfficer | 2.55K | $72.1K | Nov 19, 2025 | Merrill Lynch | SEC |
| EXASExact Sciences Corp | Nov 19, 202512:04 PM ET | Herriott JamesOfficer | 1.00K | $70.0K | Nov 19, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| ATRAAtara Biotherapeutics, Inc. | Nov 17, 20255:52 PM ET | Nguyen AnhCoDirector ยท Officer | 3.35K | $46.0K | Nov 17, 2025 | Morgan Stanley Smith Barney LLC | SEC |
| LEGNLegend Biotech Corp | Nov 17, 20255:50 PM ET | GenScript CorporationAffiliate | 203.6K | $6.17M | Nov 17, 2025 | J.P. Morgan Securities LLC | SEC |
| ATRAAtara Biotherapeutics, Inc. | Nov 17, 20255:50 PM ET | Grant-Huerta YaninaOfficer | 2.07K | $28.5K | Nov 17, 2025 | Morgan Stanley Smith Barney LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | Nov 17, 20254:29 PM ET | Fred AslanDirector ยท Officer | 6.38K | $20.7K | Nov 17, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| VIRVir Biotechnology, Inc. | Nov 17, 20253:20 PM ET | O'Byrne JasonOfficer | 6.80K | $37.8K | Nov 17, 2025 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Nov 17, 202510:06 AM ET | Boulding Mark ElliottOfficer | 2.81K | $210.9K | Nov 17, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 13, 20254:05 PM ET | Neha KrishnamohanDirector | 40.5K | $939.3K | Nov 13, 202510b5-1 | Merrill | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 12, 20254:58 PM ET | Chad RobinsOfficer | 1.88K | $27.2K | Nov 12, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| MARMarriott International Inc | Nov 12, 20259:04 AM ET | Harrison Deborah MarriottDirector ยท MEMBER OF A 13D GROUP | 70.0K | $20.4M | Nov 11, 2025 | HARBOR INVESTMENT ADVISORY LLC | SEC |
| PBYIPuma Biotechnology, Inc. | Nov 12, 20258:29 AM ET | Miller Michael PatrickDirector | 20.0K | $97.2K | Nov 11, 2025 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 12, 20258:09 AM ET | Chad RobinsOfficer | 1.24K | $18.0K | Nov 11, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 10, 20256:48 PM ET | Chad RobinsOfficer | 86.2K | $1.27M | Nov 10, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 10, 20256:48 PM ET | Harlan RobinsOfficer | 10.0K | $147.1K | Nov 10, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| MARMarriott International Inc | Nov 10, 202511:28 AM ET | Roe PeggyOfficer | 2.00K | $584.2K | Nov 10, 2025 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Nov 7, 20251:36 PM ET | Anand SatyajitOfficer | 2.74K | $787.7K | Nov 7, 2025 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Nov 7, 202511:20 AM ET | Reiss Rena HozoreOfficer | 5.48K | $1.57M | Nov 7, 2025 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Nov 7, 202510:33 AM ET | Breland Benjamin T.Officer | 1.65K | $472.1K | Nov 7, 2025 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 6, 20255:49 PM ET | Patrick BurnettOfficer | 17.3K | $417.1K | Nov 6, 202510b5-1 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 6, 20254:54 PM ETAmended | Todd EdwardsOfficer | 29.1K | $732.9K | Nov 6, 2025 | Merrill | SEC |
| MARMarriott International Inc | Nov 6, 20253:03 PM ET | Brown William POfficer | 6.67K | $1.87M | Nov 6, 2025 | Wells Fargo Clearing Services | SEC |
| AXSMAxsome Therapeutics, Inc. | Nov 5, 20257:19 PM ET | Herriot TabuteauOfficer | 21.8K | $2.95M | Nov 5, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 5, 20255:29 PM ET | Patrick BurnettOfficer | 3.85K | $91.2K | Nov 5, 202510b5-1 | Merrill Lynch | SEC |
| VIRVir Biotechnology, Inc. | Nov 5, 20259:47 AM ET | de Verneuil VaninaOfficer | 2.38K | $12.3K | Nov 5, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Nov 4, 20255:47 PM ET | Herriot TabuteauOfficer | 50.5K | $6.81M | Nov 4, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| EXASExact Sciences Corp | Nov 4, 202510:22 AM ET | Herriott JamesOfficer | 1.50K | $105.1K | Nov 4, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Nov 3, 20255:56 PM ET | Herriot TabuteauOfficer | 91.7K | $12.4M | Nov 3, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20255:49 PM ET | Masaru MatsudaOfficer | 7.21K | $178.2K | Nov 3, 2025 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20255:48 PM ET | Latha VairavanOfficer | 88 | $2.17K | Nov 3, 2025 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20255:47 PM ET | Todd Franklin WatanabeOfficer | 11.5K | $285.4K | Nov 3, 2025 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20255:47 PM ET | Patrick BurnettOfficer | 2.62K | $64.8K | Nov 3, 2025 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20254:52 PM ET | Howard WelgusDirector | 10.0K | $252.7K | Nov 3, 202510b5-1 | Merrill | SEC |
| VIRVir Biotechnology, Inc. | Nov 3, 20253:30 PM ET | de Verneuil VaninaOfficer | 1.36K | $8.00K | Nov 3, 2025 | Fidelity Brokerage Services LLC | SEC |